{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:27:21Z","timestamp":1794536841649,"version":"4.9.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Surg"],"DOI":"10.1186\/s12893-025-03089-z","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T05:10:43Z","timestamp":1754889043000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Preoperative combined biomarker model of fibrinogen-to-albumin ratio and systemic immune-inflammation index to carbohydrate antigen 19-9 ratio predicts survival in distal cholangiocarcinoma after pancreatoduodenectomy: a retrospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Fangfei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaocheng","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"key":"3089_CR1","doi-asserted-by":"publisher","unstructured":"Putatunda V, Jusakul A, Roberts L, Wang XW. Genetic, epigenetic, and microenvironmental drivers of cholangiocarcinoma. Am J Pathol. 2024;10:S0002-9440(24)00406-1. https:\/\/doi.org\/10.1016\/j.ajpath.2024.10.013.","DOI":"10.1016\/j.ajpath.2024.10.013"},{"issue":"8","key":"3089_CR2","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.4240\/wjgs.v16.i8.2689","volume":"16","author":"LA Hall","year":"2024","unstructured":"Hall LA, Loader D, Gouveia S, Burak M, Halle-Smith J, Labib P, Alarabiyat M, Marudanayagam R, Dasari BV, Roberts KJ, Raza SS, Papamichail M, Bartlett DC, Sutcliffe RP, Chatzizacharias NA. Management of distal cholangiocarcinoma with arterial involvement: systematic review and case series on the role of neoadjuvant therapy. World J Gastrointest Surg. 2024;16(8):2689\u2013701. https:\/\/doi.org\/10.4240\/wjgs.v16.i8.2689.","journal-title":"World J Gastrointest Surg"},{"issue":"1","key":"3089_CR3","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1186\/s12967-024-05854-9","volume":"22","author":"D Ma","year":"2024","unstructured":"Ma D, Wei P, Liu H, Hao J, Chen Z, Chu Y, Li Z, Shi W, Yuan Z, Cheng Q, Gao J, Zhu J, Li Z. Multi-omics-driven discovery of invasive patterns and treatment strategies in CA19-9 positive intrahepatic cholangiocarcinoma. J Transl Med. 2024;22(1):1031. https:\/\/doi.org\/10.1186\/s12967-024-05854-9.","journal-title":"J Transl Med"},{"key":"3089_CR4","doi-asserted-by":"publisher","first-page":"1402847","DOI":"10.3389\/fonc.2024.1402847","volume":"14","author":"X Dai","year":"2024","unstructured":"Dai X, Li Y, Wang H, Dai Z, Chen Y, Liu Y, Huang S. Development and validation of nomograms based on pre-\/post-operative CEA and CA19-9 for survival predicting in stage I-III colorectal cancer patients after radical resection. Front Oncol. 2024;14:1402847. https:\/\/doi.org\/10.3389\/fonc.2024.1402847.","journal-title":"Front Oncol"},{"issue":"4","key":"3089_CR5","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.surg.2024.06.049","volume":"176","author":"H Akita","year":"2024","unstructured":"Akita H, Mukai Y, Kubo M, Takahashi H, Hasegawa S, Kitakaze M, Matsuura N, Masuike Y, Sugase T, Shinno N, Kanemura T, Hara H, Sueda T, Nishimura J, Yasui M, Omori T, Miyata H, Ohue M, Wada H. A striking elevation of CA19-9 after preoperative therapy negates prognostic benefit from radical surgery in resectable and borderline resectable pancreatic cancer. Surgery. 2024;176(4):1215\u201321. https:\/\/doi.org\/10.1016\/j.surg.2024.06.049.","journal-title":"Surgery"},{"issue":"10","key":"3089_CR6","doi-asserted-by":"publisher","first-page":"4880","DOI":"10.62347\/YAWK6271","volume":"14","author":"X Guo","year":"2024","unstructured":"Guo X, Wen R, Yu L, Lin H. Tumor size, HER-2 status, CA125, CEA, SII, and PNI: key predictors of pathological complete response in LABC patients. Am J Cancer Res. 2024;14(10):4880\u201395.","journal-title":"Am J Cancer Res"},{"issue":"5","key":"3089_CR7","doi-asserted-by":"publisher","first-page":"102144","DOI":"10.1016\/j.clgc.2024.102144","volume":"22","author":"A Salari","year":"2024","unstructured":"Salari A, Ghahari M, Bitaraf M, Fard ES, Haddad M, Momeni SA, Inanloo SH, Ghahari P, Mohamoud MM, Mohamadzadeh M, Nowroozi MR, Amini E. Prognostic value of NLR, PLR, SII, and dNLR in urothelial bladder cancer following radical cystectomy. Clin Genitourin Cancer. 2024;22(5):102144. https:\/\/doi.org\/10.1016\/j.clgc.2024.102144.","journal-title":"Clin Genitourin Cancer"},{"issue":"3","key":"3089_CR8","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1245\/s10434-019-08094-0","volume":"27","author":"P Murthy","year":"2020","unstructured":"Murthy P, Zenati MS, Al Abbas AI, Rieser CJ, Bahary N, Lotze MT, Zeh HJ III, Zureikat AH, Boone BA. Prognostic value of the systemic Immune-Inflammation index (SII) after neoadjuvant therapy for patients with resected pancreatic Cancer. Ann Surg Oncol. 2020;27(3):898\u2013906. https:\/\/doi.org\/10.1245\/s10434-019-08094-0.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"3089_CR9","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12957-024-03506-2","volume":"22","author":"Z Wang","year":"2024","unstructured":"Wang Z, Shen X. Prognostic and clinicopathological significance of fibrinogen-to-albumin ratio (FAR) in patients with breast cancer: a meta-analysis. World J Surg Oncol. 2024;22(1):220. https:\/\/doi.org\/10.1186\/s12957-024-03506-2.","journal-title":"World J Surg Oncol"},{"key":"3089_CR10","doi-asserted-by":"publisher","first-page":"1396843","DOI":"10.3389\/fonc.2024.1396843","volume":"14","author":"S Ma","year":"2024","unstructured":"Ma S, Wang L. Fibrinogen-to-albumin ratio (FAR) is the best biomarker for the overall survival of patients with non-small-cell lung cancer. Front Oncol. 2024;14:1396843. https:\/\/doi.org\/10.3389\/fonc.2024.1396843.","journal-title":"Front Oncol"},{"key":"3089_CR11","doi-asserted-by":"publisher","first-page":"1381967","DOI":"10.3389\/fmed.2024.1381967","volume":"11","author":"W Lu","year":"2024","unstructured":"Lu W, Wang H, Lin S, Chang X, Wang J, Wu X, Yu X. The association between the fibrinogen-to-albumin ratio and delirium after deep brain stimulation surgery in parkinson\u2019s disease. Front Med (Lausanne). 2024;11:1381967.","journal-title":"Front Med (Lausanne)"},{"issue":"8","key":"3089_CR12","doi-asserted-by":"publisher","first-page":"e18797","DOI":"10.1016\/j.heliyon.2023.e18797","volume":"9","author":"J Zhong","year":"2023","unstructured":"Zhong J. Fibrinogen-to-albumin ratios are related to mortality in patients with secondary malignant neoplasm of bone and bone marrow. Heliyon. 2023;9(8):e18797. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e18797.","journal-title":"Heliyon"},{"key":"3089_CR13","doi-asserted-by":"crossref","unstructured":"Labib PL, Russell TB, Denson JL, Puckett MA, Ausania F, et al. RAW study collaborators; Aroori S. Patterns, timing and predictors of recurrence following pancreaticoduodenectomy for distal cholangiocarcinoma: an international multicentre retrospective cohort study. Eur J Surg Oncol. 2024;50(6):108353.","DOI":"10.1016\/j.hpb.2024.03.882"},{"issue":"7","key":"3089_CR14","doi-asserted-by":"publisher","first-page":"108375","DOI":"10.1016\/j.ejso.2024.108375","volume":"50","author":"M Perez","year":"2024","unstructured":"Perez M, Palnaes Hansen C, Burdio F, Sanchez-Vel\u00e1zquez P, Giuliani A, et al. A machine learning predictive model for recurrence of resected distal cholangiocarcinoma: development and validation of predictive model using artificial intelligence. Eur J Surg Oncol. 2024;50(7):108375.","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"3089_CR15","doi-asserted-by":"publisher","first-page":"108691","DOI":"10.1016\/j.ejso.2024.108691","volume":"50","author":"T Kato","year":"2024","unstructured":"Kato T, Okada K, Baba Y, Yasuda M, Ohshima Y, Takase K, Watanabe Y, Aikawa M, Okamoto K, Koyama I. Preoperative prognostic stratification and prediction of long-term outcomes after pancreatoduodenectomy for distal cholangiocarcinoma. Eur J Surg Oncol. 2024;50(12):108691. https:\/\/doi.org\/10.1016\/j.ejso.2024.108691. Epub ahead of print. PMID: 39366161.","journal-title":"Eur J Surg Oncol"},{"issue":"22","key":"3089_CR16","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.3390\/diagnostics13223406","volume":"13","author":"H Yoshii","year":"2023","unstructured":"Yoshii H, Izumi H, Fujino R, Kurata M, Inomoto C, Sugiyama T, Nakagohri T, Nomura E, Mukai M, Tajiri T. Subserosal layer and\/or pancreatic invasion based on anatomical features as a novel prognostic Indicator in patients with distal cholangiocarcinoma. Diagnostics (Basel). 2023;13(22):3406. https:\/\/doi.org\/10.3390\/diagnostics13223406.","journal-title":"Diagnostics (Basel)"},{"key":"3089_CR17","doi-asserted-by":"publisher","first-page":"111298","DOI":"10.1016\/j.ejrad.2024.111298","volume":"171","author":"C Zhang","year":"2024","unstructured":"Zhang C, Wang L, Zheng Z, Wang L, Xiao Y, Zhao B, Dong H, Li J. Optimized early recurrence score for distal cholangiocarcinoma: a new attempt by adding imaging indicators. Eur J Radiol. 2024;171:111298. https:\/\/doi.org\/10.1016\/j.ejrad.2024.111298.","journal-title":"Eur J Radiol."},{"issue":"7","key":"3089_CR18","doi-asserted-by":"publisher","first-page":"540","DOI":"10.4149\/BLL_2023_083","volume":"124","author":"V Tosun","year":"2023","unstructured":"Tosun V, Opan S, An I. Measurement of epicardial fatty tissue thickness has a diagnostic value in lichen planus patients and is associated with fibrinogen to albumin ratio and neutrophil to lymphocyte ratio. Bratisl Lek Listy. 2023;124(7):540\u20134. https:\/\/doi.org\/10.4149\/BLL_2023_083. PMID: 37218482.","journal-title":"Bratisl Lek Listy"},{"issue":"2","key":"3089_CR19","doi-asserted-by":"publisher","first-page":"202","DOI":"10.5230\/jgc.2020.20.e18","volume":"20","author":"W Gao","year":"2020","unstructured":"Gao W, Zhang F, Ma T, Hao J. High preoperative fibrinogen and systemic inflammation response index (F-SIRI) predict unfavorable survival of resectable gastric Cancer patients. J Gastric Cancer. 2020;20(2):202\u201311. https:\/\/doi.org\/10.5230\/jgc.2020.20.e18.","journal-title":"J Gastric Cancer"},{"issue":"46","key":"3089_CR20","doi-asserted-by":"publisher","first-page":"7382","DOI":"10.3748\/wjg.v26.i46.7382","volume":"26","author":"LP Zhang","year":"2020","unstructured":"Zhang LP, Ren H, Du YX, Wang CF. Prognostic value of the preoperative fibrinogen-to-albumin ratio in pancreatic ductal adenocarcinoma patients undergoing R0 resection. World J Gastroenterol. 2020;26(46):7382\u2013404. https:\/\/doi.org\/10.3748\/wjg.v26.i46.7382.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"3089_CR21","doi-asserted-by":"publisher","first-page":"188655","DOI":"10.1016\/j.bbcan.2021.188655","volume":"1877","author":"L Yu","year":"2022","unstructured":"Yu L, Hua Z, Luo X, Zhao T, Liu Y. Systematic interaction of plasma albumin with the efficacy of chemotherapeutic drugs. Biochim Biophys Acta Rev Cancer. 2022;1877(1):188655. https:\/\/doi.org\/10.1016\/j.bbcan.2021.188655.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"2","key":"3089_CR22","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3390\/cancers14020344","volume":"14","author":"LNC Boyd","year":"2022","unstructured":"Boyd LNC, Ali M, Kam L, Puik JR, Rodrigues SMF, Zwart ES, Daams F, Zonderhuis BM, Meijer LL, Le Large TYS, Giovannetti E, van Laarhoven HWM, Kazemier G. The diagnostic value of the CA19-9 and bilirubin ratio in patients with pancreatic cancer, distal bile duct cancer and benign periampullary diseases, a novel approach. Cancers (Basel). 2022;14(2):344. https:\/\/doi.org\/10.3390\/cancers14020344.","journal-title":"Cancers (Basel)"},{"key":"3089_CR23","doi-asserted-by":"publisher","first-page":"5555","DOI":"10.2147\/JIR.S474263","volume":"17","author":"Y Xu","year":"2024","unstructured":"Xu Y, Zhang L, Chen Z, Sun X, Zhao M, Wu Q, Hao J. The diagnostic value of systemic immune-inflammatory index (SII) and lymphocyte-albumin-neutrophil ratio (LANR) in chronic obstructive pulmonary disease with lung cancer. J Inflamm Res. 2024;17:5555\u201365.","journal-title":"J Inflamm Res"},{"issue":"15","key":"3089_CR24","doi-asserted-by":"publisher","first-page":"8441","DOI":"10.3390\/ijms25158441","volume":"25","author":"O Menyhart","year":"2024","unstructured":"Menyhart O, Fekete JT, Gy\u0151rffy B. Inflammation and colorectal cancer: a meta-analysis of the prognostic significance of the systemic immune-inflammation index (SII) and the systemic inflammation response index (SIRI). Int J Mol Sci. 2024;25(15):8441. https:\/\/doi.org\/10.3390\/ijms25158441.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"3089_CR25","doi-asserted-by":"publisher","first-page":"e345","DOI":"10.1097\/SLA.0000000000005678","volume":"277","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Li Q, Wang X, et al. Multidimensional biomarker integration overcomes limitations of anatomical staging in cholangiocarcinoma. Ann Surg. 2023;277(5):e345\u201355. https:\/\/doi.org\/10.1097\/SLA.0000000000005678.","journal-title":"Ann Surg"},{"issue":"2","key":"3089_CR26","doi-asserted-by":"publisher","first-page":"108691","DOI":"10.1016\/j.ejso.2023.108691","volume":"50","author":"T Kato","year":"2024","unstructured":"Kato T, Okada K, Baba Y, et al. Preoperative prognostic stratification using CT-Based radiomics and CA19-9 kinetics in distal cholangiocarcinoma. Eur J Surg Oncol. 2024;50(2):108691. https:\/\/doi.org\/10.1016\/j.ejso.2023.108691.","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"3089_CR27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41389-021-00375-2","volume":"11","author":"Y Zhang","year":"2022","unstructured":"Zhang Y et al. Fibrinogen-integrin \u03b1v\u03b23 interaction induces epithelial-mesenchymal transition via TGF-\u03b2\/Smad3 signaling in cholangiocarcinoma. Oncogenesis. 2022;11(1):48.","journal-title":"Oncogenesis"},{"issue":"12","key":"3089_CR28","first-page":"e003785","volume":"9","author":"H Tang","year":"2021","unstructured":"Tang H, et al. CA19-9 drives PD-L1 upregulation via galectin-3\/MUC1\/EGFR axis to suppress CD8\u2009+\u2009T-cell function in biliary tract cancer. J Immunother Cancer. 2021;9(12):e003785.","journal-title":"J Immunother Cancer"}],"container-title":["BMC Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-025-03089-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12893-025-03089-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-025-03089-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T16:14:07Z","timestamp":1757348047000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcsurg.biomedcentral.com\/articles\/10.1186\/s12893-025-03089-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3089"],"URL":"https:\/\/doi.org\/10.1186\/s12893-025-03089-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6551432\/v1","asserted-by":"object"}]},"ISSN":["1471-2482"],"issn-type":[{"value":"1471-2482","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Beijing Chaoyang Hospital (Approval Number: 2024-D-511). Written informed consent was obtained from all participants or their legal guardians, and all subjects have signed the informed consent form and explicitly agreed to participate in the study. All procedures adhered to the ethical standards of the 1964 Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"363"}}